Antoine Flahault

Prof. Dr. Antoine Flahault

University of Geneva, Institute of Global Health
+1
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
SASalem T. Argaw
Salem T. Argaw
JTJuan R. Troncoso-Pastoriza
Juan R. Troncoso-Pastoriza
DLDarren Lacey
Darren Lacey
MFMarie-Valentine Florin
Marie-Valentine Florin
FCFranck Calcavecchia
Franck Calcavecchia
Antoine FlahaultAntoine Flahault
Antoine Flahault

11 January 2019 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
SASalem T. Argaw
Salem T. Argaw
NBNefti-Eboni Bempong
Nefti-Eboni Bempong
BEBruce Eshaya-Chauvin
Bruce Eshaya-Chauvin
Antoine FlahaultAntoine Flahault
Antoine Flahault
The health sector has quickly become a target for cyberattacks. Hospitals are especially sensitive to these sorts of attacks as any disruption in operations or even disclosure of patient personal information can have far-reaching consequences. The objective of this study was to map the available literature on cyberattacks on hospitals and to identify the different domains of research, while extracting the recommendations and guidelines put forth in the literature. Four databases (PubMed, Web of Science, ProQuest, and Scopus) were searched using standardized and adapted search syntax in order to identify relevant manuscripts published between 1997 and 2017. These were screened by two reviewers and included or excluded based on inclusion and exclusion criteria. Data from articles were then extracted and analyzed. The search identified 818 records of which 97 were included. Of the 97, 32% were published in 2017 while around 40% of the articles were published prior to the last three years. Six domains of research emerged through the analysis, which are included here: context and trends in cybersecurity (27.8%), connected medical devices and equipment (29.9%), hospital information systems (14.4%), raising awareness and lessons learned (6.2%), information security methodology (15.4%), and specific types of attacks (6.2%). There is a generally growing interest in the research field, but the available literature remains limited in number. There are important aspects of cybersecurity (e.g. cloud storage and access management) as well as specific medical fields that rely on various medical devices that have been neglected. Recommendations are available, but comprehensive guidelines and standardized best practice measures are still necessary.

24 October 2020 in International Journal of Public Health
Verified
Journal Article
Open access
PDF file
TGthe Corona Immunitas Research Group
the Corona Immunitas Research Group
EWErin A. West
Erin A. West
DADaniela Anker
Daniela Anker
RARebecca Amati
Rebecca Amati
Aude RichardAude Richard
Aude Richard
MPMilo A. Puhan
Milo A. Puhan
Objectives: Seroprevalence studies to assess the spread of SARS-CoV-2 infection in the general population and subgroups are key for evaluating mitigation and vaccination policies and for understanding the spread of the disease both on the national level and for comparison with the international community. Methods: Corona Immunitas is a research program of coordinated, population-based, seroprevalence studies implemented by Swiss School of Public Health (SSPH+). Over 28,340 participants, randomly selected and age-stratified, with some regional specificities will be included. Additional studies in vulnerable and highly exposed subpopulations are also planned. The studies will assess population immunological status during the pandemic. Results: Phase one (first wave of pandemic) estimates from Geneva showed a steady increase in seroprevalence up to 10.8% (95% CI 8.2–13.9, n = 775) by May 9, 2020. Since June, Zurich, Lausanne, Basel City/Land, Ticino, and Fribourg recruited a total of 5973 participants for phase two thus far. Conclusions: Corona Immunitas will generate reliable, comparable, and high-quality serological and epidemiological data with extensive coverage of Switzerland and of several subpopulations, informing health policies and decision making in both economic and societal sectors. ISRCTN Registry: https://www.isrctn.com/ISRCTN18181860.

13 February 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
YLYejin Lee
Yejin Lee
MRMario C Raviglione
Mario C Raviglione
Antoine FlahaultAntoine Flahault
Antoine Flahault
Background: Tuberculosis (TB) is the leading cause of death from a single infectious agent, with around 1.5 million deaths reported in 2018, and is a major contributor to suffering worldwide, with an estimated 10 million new cases every year. In the context of the World Health Organization’s End TB strategy and the quest for digital innovations, there is a need to understand what is happening around the world regarding research into the use of digital technology for better TB care and control. Objective: The purpose of this scoping review was to summarize the state of research on the use of digital technology to enhance TB care and control. This study provides an overview of publications covering this subject and answers 3 main questions: (1) to what extent has the issue been addressed in the scientific literature between January 2016 and March 2019, (2) which countries have been investing in research in this field, and (3) what digital technologies were used? Methods: A Web-based search was conducted on PubMed and Web of Science. Studies that describe the use of digital technology with specific reference to keywords such as TB, digital health, eHealth, and mHealth were included. Data from selected studies were synthesized into 4 functions using narrative and graphical methods. Such digital health interventions were categorized based on 2 classifications, one by function and the other by targeted user. Results: A total of 145 relevant studies were identified out of the 1005 published between January 2016 and March 2019. Overall, 72.4% (105/145) of the research focused on patient care and 20.7% (30/145) on surveillance and monitoring. Other programmatic functions 4.8% (7/145) and electronic learning 2.1% (3/145) were less frequently studied. Most digital health technologies used for patient care included primarily diagnostic 59.4% (63/106) and treatment adherence tools 40.6% (43/106). On the basis of the second type of classification, 107 studies targeted health care providers (107/145, 73.8%), 20 studies targeted clients (20/145, 13.8%), 17 dealt with data services (17/145, 11.7%), and 1 study was on the health system or resource management. The first authors’ affiliations were mainly from 3 countries: the United States (30/145 studies, 20.7%), China (20/145 studies, 13.8%), and India (17/145 studies, 11.7%). The researchers from the United States conducted their research both domestically and abroad, whereas researchers from China and India conducted all studies domestically. Conclusions: The majority of research conducted between January 2016 and March 2019 on digital interventions for TB focused on diagnostic tools and treatment adherence technologies, such as video-observed therapy and SMS. Only a few studies addressed interventions for data services and health system or resource management.

22 December 1998 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
PDF file
EBEric Bonabeau
Eric Bonabeau
Laurent ToubianaLaurent Toubiana
Laurent Toubiana
Antoine FlahaultAntoine Flahault
Antoine Flahault
How infectious diseases spread in space within one cycle of an epidemic is an important question that has received considerable theoretical attention. There are, however, few empirical studies to support theoretical approaches, because data is scarce. Weekly reports obtained since 1984 from a network of general practitioners spanning the entire French territory allows the analysis of the spatio–temporal dynamics of influenza over a fine spatial scale. This analysis indicates that diffusion over long distances, possibly due to global transportation systems, is so quick that homogeneous global mixing occurs before the epidemic builds up within infected patches. A simple model in which the total number of cases is given by the empirical time–series and cases are randomly assigned to patches according to the population weight of the patches exhibits the same spatio–temporal properties as real epidemic cycles: homogeneous mixing models constitute appropriate descriptions, except in the vicinity of the epidemic's peak, where geographic heterogeneities play a role.

15 August 2018 in Public Health Reviews
Verified
Journal Article
Open access
PDF file
SSStefanie Schütte
Stefanie Schütte
DDDamien Dietrich
Damien Dietrich
XMXavier Montet
Xavier Montet
Antoine FlahaultAntoine Flahault
Antoine Flahault
Lung cancer remains the leading cause of cancer mortality worldwide. A number of screening trials for early detection of lung cancer exist, using chest X-ray, low-dose computed tomography, or both. However, little is known about the socio-demographic characteristics of participants in lung cancer screening programs. As gender and socio-economic determinants are important variables to consider for successful program implementation, this review aims to characterize the participants in such programs and to investigate whether differences in representation exist across screening programs. Systematic methods were used to identify relevant studies. A search was undertaken to locate all studies published up to August 2017 assessing the socio-demographic profile of participants in lung cancer screening programs. A search strategy was developed, refined, and implemented to search in two different online databases (MEDLINE and Web of Sciences). A total of 1588 references were retrieved of which 14 were eligible for review. The results highlight differences in gender and social characteristics of participants across programs, while noting that differences may be partly explained by the various epidemiological contexts, program inclusion criteria, and socio-economic status (SES) measures collected. Most importantly, despite a well-recognized predominance of low SES among heavy smokers, people with high SES are seemingly over-represented among participants. Male participants also seem to be over-represented. These findings are important to help inform the development and implementation processes of future lung cancer screening programs, which should likely include strategies for engaging women as well as individuals with low SES and, of course, those most at risk for developing lung cancer.